Aurinia Pharmaceuticals Newsroom

Insiders At Aurinia Pharmaceuticals Sold US$2.0m In Stock, Alluding To Potential Weakness

Simply Wall StNov 22 18:44

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Siemens Healthineers AG (OtherSEMHF)

TipRanksNov 20 09:40 · Ratings

Aurinia Pharmaceuticals Celebrates New Lupus Nephritis Guidelines

TipRanksNov 19 07:42

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BusinesswireNov 19 06:53

Express News | Aurinia Commends 2024 Updated Acr Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BreakingsNov 19 06:53

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS in Managing LN at American College of Rheumatology Convergence 2024

BusinesswireNov 15 19:00

Express News | Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of Lupkynis® in Managing Ln at American College of Rheumatology Convergence 2024

BreakingsNov 15 19:00

Aurinia to Participate in Jefferies London Healthcare Conference

BusinesswireNov 14 19:00

RBC Capital Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $9

Futu NewsNov 11 20:31 · Ratings

Bloom Burton Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $10.85

Futu NewsNov 11 17:34 · Ratings

Positive Outlook on Aurinia Pharmaceuticals Amid Strong Financial Performance and Strategic Cost Management

TipRanksNov 11 16:35

Leerink Partners Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating

Futu NewsNov 8 15:32 · Ratings

Aurinia Pharmaceuticals Reports Strong Growth and Strategic Restructuring

TipRanksNov 8 12:38

Aurinia Pharmaceuticals Inc (AUPH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

InvestingNov 8 09:12

Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 8 00:47 · Conference Call

TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $11

Futu NewsNov 8 00:31 · Ratings

Aurinia Pharmaceuticals: Strong Growth Prospects Bolstered by Lupkynis Sales and Promising Pipeline

TipRanksNov 7 23:55

Aurinia Pharmaceuticals Reports Q3 Beat, Plans to Cut Workforce by 45%; Shares Rise

MT NewswiresNov 7 23:41

Aurinia Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 7 19:23 · Announcements

Aurinia Pharmaceuticals | 8-K: Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS ® Growth and AUR200 Development

SECNov 7 19:18